Position in TBPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$126,770,020
+$5,741,937 QoQ
Shares Held
7,457,060
0.0% QoQ
Ownership
14.4%
of shares outstanding
% of Portfolio
2.08%
of 13F equity value
Holder Rank
#2
of 179 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Weiss Asset Management LP holds $396,341,883 across 27 Biotechnology names. TBPH ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
This page
|
7,457,060 | $126,770,020 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
2,542,652 | $89,984,454 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
2,581,813 | $50,267,899 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
320,184 | $23,847,304 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
375,082 | $20,607,005 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
80,000 | $19,581,600 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
134,014 | $10,923,481 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
19,325 | $10,376,558 |
All Filings in TBPH
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,770,020 | 7,457,060 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $121,028,083 | 7,457,060 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $139,521,592 | 7,457,060 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $108,873,076 | 7,457,060 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $82,251,371 | 7,457,060 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $66,591,545 | 7,457,060 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $70,170,934 | 7,457,060 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $60,103,903 | 7,457,060 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $63,235,868 | 7,457,060 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $66,889,828 | 7,457,060 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $83,817,354 | 7,457,060 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $64,354,427 | 7,457,060 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $77,180,571 | 7,457,060 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $80,909,101 | 7,457,060 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $83,668,213 | 7,457,060 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $75,614,588 | 7,457,060 | Shares | Defined | 2022-12-05 | |
| 2022-06-30 | $56,511,188 | 6,237,438 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,743,375 | 5,412,487 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,749,646 | 2,601,778 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||